ArticleRenal failure2026
Machine learning prediction of CKD progression in hyperglycemic elderly adults: a prospective community cohort study.
Article in Renal failure, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hyperglycemia is a major risk factor for chronic kidney disease (CKD). This multicenter prospective study developed and validated a machine learning (ML) model to predict CKD risk in prediabetic and diabetic populations for early intervention, following TRIPOD+AI guidelines. Participants were enrolled from four communities, with three sites providing training (80%) and internal test (20%) datasets, and the fourth for external validation. Five ML algorithms were constructed, and SHapley Additive exPlanations (SHAP) was applied to interpret the optimal model. The XGBoost model showed excellent predictive performance, with AUCs of 0.905, 0.809, and 0.837 in training, internal test, and external validation sets, respectively. Serum creatinine (Scr), age, and hemoglobin (Hb) were the leading predictors, with higher Scr, older age, and lower Hb elevating CKD risk. Risk stratification (low: 0%-5%, medium: 5%-25%, high: 25%-100%) yielded distinct CKD incidences of 0.7%, 9.9%, and 55.5% (
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.